NorthCrest Asset Manangement’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$231K Buy
+4,719
New +$203K 0.01% 814
2026
Q1
Sell
-9,249
Closed -$510K 838
2025
Q4
$510K Sell
9,249
-1,421
-13% -$72.7K 0.01% 534
2025
Q3
$630K Buy
10,670
+137
+1% +$8.02K 0.02% 433
2025
Q2
$729K Sell
10,533
-230
-2% -$15.6K 0.02% 357
2025
Q1
$747K Sell
10,763
-900
-8% -$74.3K 0.02% 349
2024
Q4
$1M Buy
11,663
+495
+4% +$53.5K 0.03% 295
2024
Q3
$1.33M Buy
11,168
+331
+3% +$44.1K 0.04% 249
2024
Q2
$1.55M Buy
10,837
+232
+2% +$30.7K 0.05% 225
2024
Q1
$1.36M Buy
10,605
+488
+5% +$58.1K 0.05% 239
2023
Q4
$1.05M Buy
10,117
+73
+0.7% +$7.22K 0.04% 261
2023
Q3
$913K Hold
10,044
0.04% 269
2023
Q2
$813K Hold
10,044
0.03% 285
2023
Q1
$799K Buy
10,044
+784
+8% +$55.6K 0.03% 291
2022
Q4
$627K Hold
9,260
0.04% 242
2022
Q3
$461K Hold
9,260
0.03% 313
2022
Q2
$516K Hold
9,260
0.03% 302
2022
Q1
$514K Buy
+9,260
New +$475K 0.02% 294

Other funds holding NVO

NorthCrest Asset Manangement's NVO Position: Q2 2026 in Review

NorthCrest Asset Manangement opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,719 shares worth $231K. The stake represents 0.01% of the portfolio and ranks #814 among its holdings. This is a return to the name: NorthCrest Asset Manangement previously reported a position in NVO as recently as Q4 2025.

NorthCrest Asset Manangement first reported a position in NVO in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.55M in Q2 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • NorthCrest Asset Manangement held 4,719 shares of Novo Nordisk worth $231K as of Q2 2026.
  • Novo Nordisk was a new NorthCrest Asset Manangement position in Q2 2026.
  • Novo Nordisk made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #814 holding.
  • NorthCrest Asset Manangement first reported a position in Novo Nordisk in Q1 2022 and has held it in 17 quarters since.
  • NorthCrest Asset Manangement's Novo Nordisk position peaked at $1.55M in Q2 2024.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.